Express Scripts Formulary for “Digital Health” Offers Long Overdue Info July 10, 2019 In mid-May, Express Scripts announced that it plans to introduce what it says is the healthcare industry’s first stand-alone digital health formulary. This may... ...
Cathy Kelly
The article focuses on the addition of the cholesterol-lowering drugs such as PCSK9 inhibitors Praluent and Repatha to the National Preferred Formulary of Express Scripts, a pharmacy benefit management organization.doi:10.1007/s40274-015-2548-1None...
The question we are asked most often is about how to talk to Express Scripts customer service. Click here for contact information, email and chat options, getting a live person, wait times and more. Can I request a medication not listed on the formulary? Yes, you can request a medication ...
(which became Surescripts), promoting e-prescribing, and focusing on adherence (a relatively new phenomenon). But, they’ve also complicated pharmacist’s lives with utilization management and formulary programs and driving mail order. Would some other solution have come up if th...
“The inclusion of our interchangeable biosimilar insulin glargine in Express Scripts’ National Preferred Formulary® (NPF) in the U.S. is a major milestone for Biocon Biologics. It furthers our mission of enabling affordable ...
Express Scripts Adds Biosimilar SEMGLEE to Preferred Formulary November 3, 2021 Gabriella Montes Biosimilars News,Express Scripts,Semglee In October, Express Scripts announced that it would add Viatris’ SEMGLEE (insulin glargine-yfgn) injection as a preferred therapy on its formulary beginning in Januar...
Express Scripts and AbbVie Ink Landmark Formulary Exclusivity DealRandi Hernandez
Express Scripts may switch hepatitis C drugs on preferred formularyWhile pharmaceutical manufacturer AbbVie's new hepatitis C drug has not yet been approved by FDA, pharmacy benefits manager Express Scripts has expressed interest in switching to the drug in its preferred drug formula...
How Express Scripts will manage pricey cholesterol drugsChristine BlankContributing Editor